Similasan Graphites compositum, Augentropfen
7680693280014
CH-69328
Augentropfen
Associated product:
Similasan Graphites compositum, Augentropfen
1 / 3
google
Article details
- Package size
- 10
- Selling units
- 10
- Measure
- ml
- Galenic form
- Augentropfen
- Galenic group
- Augenmittel
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
0.227 ML | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
0.227 ML | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
0.227 ML | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
0.227 ML | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Authorization holder
T&S Eye Care Management AG
6060 Sarnen
Authorization information
- Swissmedic authorization number
- 69328
- Drug name
- Similasan Graphites compositum, Augentropfen
- Galenic form
- AUL
- Authorization status
- Z
- Dispensing category
- D
- First authorization
- 14/06/2024
- Authorization expiration date
- 13/06/2029
- IT Number
- 20.01.1.
- Domain
- Human medicine
Package details
- Description (FR)
- SIMILASAN Graphites compositum gtt opht 0.227 ml 1
- Description (DE)
- SIMILASAN Graphites compositum Trp Opht 0.227 ml 1
- Market launch
- 15/01/2026
- Narcotic (BTM)
- No